Director of Endocrinology
Dr. Henriksen joined Nordic Bioscience in 2002 and assumed the position of director of endocrinology in 2018. His research focuses on the identification and development of novel peptide therapies for metabolic diseases such as obesity, NASH, and type 2 diabetes, and has led to the patenting and development of two families of peptides, KBPs and OXMs, which are rapidly moving toward clinical development.
H-index: 56, i10-index: 136, Citations 10832
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
